ATP5PDP2

Across TCGA pan-cancer cohorts, ATP5PDP2 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated ATP5PDP2 data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher ATP5PDP2 RNA is associated with better overall survival. In most high-consensus cancer types, elevated ATP5PDP2 expression acts as an unfavorable survival marker, although some lineages such as THCA and BLCA show a favorable association.

THCA, LUAD, and ACC are the cancer types where ATP5PDP2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Median	All	0.996	0.955	.001	66	view →
LUAD	DFS	Median	All	0.742	0.837	<.001	43	view →
ACC	OS	Quartile	II,III,IV	0.694	0.902	.006	34	view →
BLCA	DFS	Median	II,III,IV	0.690	0.558	.003	30	view →
THYM	DFS	Quartile	III,IV	0.428	1.000	.007	27	view →
KICH	OS	Tertile	II,III,IV	0.883	1.000	.023	25	view →
OV	OS	Tertile	All	0.875	0.789	.025	22	view →
CESC	OS	Median	II,III,IV	0.853	0.666	.009	12	view →
PRAD	DFS	Tertile	All	0.855	0.730	.009	12	view →
BRCA	OS	Tertile	III,IV	0.967	0.869	.016	9	view →
COAD	DFS	Quartile	IV	0.196	0.409	.029	9	view →
KIRC	OS	Tertile	All	0.761	0.617	.023	7	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

ATP5PDP2–THCA (OS)

Open the THCA breakdown →